What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Her primary areas of investigation include Cancer, Internal medicine, Surgery, Cohort study and Clinical trial.
Her Cancer study combines topics from a wide range of disciplines, such as Gerontology, Medical record, Confidence interval, Gynecology and Intensive care unit.
Her Internal medicine study frequently links to related topics such as Oncology.
The study incorporates disciplines such as Quality of life and Cohort in addition to Surgery.
Her work deals with themes such as Colorectal cancer, Retrospective cohort study and Intensive care medicine, which intersect with Cohort study.
Her studies in Clinical trial integrate themes in fields like Family medicine and Therapeutic misconception, Informed consent.
Her most cited work include:
- Relationship Between Cancer Patients' Predictions of Prognosis and Their Treatment Preferences (995 citations)
- Symptoms and suffering at the end of life in children with cancer. (903 citations)
- Patients’ Expectations about Effects of Chemotherapy for Advanced Cancer (711 citations)
What are the main themes of her work throughout her whole career to date?
Jane C. Weeks mainly investigates Internal medicine, Cancer, Oncology, Surgery and Breast cancer.
Her Cancer research is multidisciplinary, incorporating perspectives in Prospective cohort study, Logistic regression, Cohort study and Outcomes research.
Her research in Cohort study intersects with topics in Retrospective cohort study and Intensive care medicine.
Her Surgery study combines topics in areas such as Clinical trial and Quality of life.
In her research, Informed consent is intimately related to Family medicine, which falls under the overarching field of Clinical trial.
Her Breast cancer research is multidisciplinary, relying on both Odds ratio and Gynecology.
She most often published in these fields:
- Internal medicine (53.01%)
- Cancer (45.36%)
- Oncology (34.43%)
What were the highlights of her more recent work (between 2010-2016)?
- Internal medicine (53.01%)
- Cancer (45.36%)
- Oncology (34.43%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Internal medicine, Cancer, Oncology, Breast cancer and Surgery.
Jane C. Weeks interconnects Odds ratio, Cohort study, Confidence interval, Gynecology and Stage in the investigation of issues within Cancer.
Her Oncology study integrates concerns from other disciplines, such as Palliative Radiation Therapy, Radiosurgery, Randomized controlled trial and Chemotherapy.
Her Breast cancer research includes themes of Body mass index, Comorbidity and Cancer Care Facilities.
Her Surgery study incorporates themes from Mastectomy, Prostate cancer and Cohort.
She focuses mostly in the field of Mammaplasty, narrowing it down to matters related to Multivariate analysis and, in some cases, Clinical trial.
Between 2010 and 2016, her most popular works were:
- Patients’ Expectations about Effects of Chemotherapy for Advanced Cancer (711 citations)
- Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network (313 citations)
- Family Perspectives on Aggressive Cancer Care Near the End of Life. (210 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Jane C. Weeks mainly focuses on Internal medicine, Cancer, Oncology, Lung cancer and Surgery.
Her biological study spans a wide range of topics, including Gynecology and Cohort study.
Her Cohort study research is multidisciplinary, incorporating elements of Dose fractionation and Medical record.
Her Oncology research includes elements of Stage and Breast cancer.
She has included themes like Physical therapy and Outcomes research in her Lung cancer study.
The various areas that she examines in her Surgery study include Mastectomy and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
